Drugs / FS VH S/D 500 s-apr
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02891070 | Oct 2016 → Aug 2018 | cerebrospinal fluid leak | Baxter Healthcare Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FS VH S/D 500 s-apr | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02891070 ↗ |
| Modality | Protein / enzyme biologic | “Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated” NCT02891070 ↗ |